Come up with a name for your new list and we'll add to it:
CONTINUUS Pharmaceuticals raised a round of funding on June 25, 2014. Investors include
Oxford Bioscience Partners.
CONTINUUS Pharmaceuticals is an early-stage company spin-out of the Novartis-MIT Center for Continuous Manufacturing. Rather than producing medicines through batch-wise, step-by-step processes, CONTIN…